Daily Short Volume Overview
Recent data from FINRA Reg SHO indicates that Protalix BioTherapeutics (PLX) has experienced notable short selling pressure. As of the most recent reporting period, the daily short volume reached 29.8% of total trading volume. While this represents a decrease from the 41-day average of 43.9%, the absolute volume of 52.5K shares marked short out of 176.1K total shares traded highlights continued bearish interest in the name. It is critical to note that this figure represents daily flow—the number of shares marked short during the trading session—rather than the total open short interest position.
Signal data sourced from FINRA. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.